Skip to content

Launched

Simplify VettaFi Private Credit Strategy ETF

PCRNYSE ArcaSimplifyThis fund does not currently behave like the group it was assigned to, so its grouping is being re-reviewed. Grading pauses until the review resolves, because a letter measured against the wrong peer group would be a statement about the wrong funds.

$17.840.00 (0.00%)

As of Oct 21, 2026, 9:46 AM ET

Intraday session: flat, 1 prints from 17.84 to 17.84. Range 17.84 to 17.84. Use the arrow keys to read each point.17.0017.5018.5010 AM12 PM2 PM4 PM
Expense ratio
0.76%
Fund size
$2M
1Y total return
−16.5%
Yield · Last 12 months
Data unavailable
Holdings
5
Avg volume · 30D
729 sh
NAV per share
$17.84
52W range
low $17.50high $24.89
Launched

The ETF.net PCR Grade

—

Under classification review

This fund does not currently behave like the group it was assigned to, so its grouping is being re-reviewed. Grading pauses until the review resolves, because a letter measured against the wrong peer group would be a statement about the wrong funds.

PCR Holdings

As of Oct 20, 2026
Asset class
Other
Holdings
5
Top-10 weight
100%
Largest holding
B 12/31/26 Govt68.0%

Geography

  • United States100.00%
The fund’s holdings, weight-ordered — page 1 of 1.
#TickerCompanyWeight %SharesMarket valueHeld by ETFs
1—B 12/31/26 Govt68.05%1,530,000$1.52M38
2TUASimplify E Short Term Trsry Futures20.61%23,740$460K1
3—B 3/11/27 Govt8.82%200,000$197K29
4—Cash1.41%31,549$31.5K108
5—B 1/28/27 Govt1.11%25,000$24.7K32

Showing 1–5 of 5 holdings

PCR Performance

Launched Sep 22, 2025

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
PCR$8,353
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,580
Oct 20, 2025 to Oct 20, 2026. PCR $8,353. SPY $11,580. Use the arrow keys to read each point.$8,000$10,000$12,000Oct 2025Apr 2026Oct 2026

Oct 20, 2025 – Oct 20, 2026

Returns run to the Oct 20, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PCR. Periods over one year show the average yearly return.
PeriodPCR
Year to date−15.5%
1 month−3.0%
3 months−3.8%
1 year−16.5%
3 yearsFund is under 3 years oldper year—
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PCR
YearReturn barPCR
2026 YTD−15.5%
2025−5.8%

History from Sep 23, 2025

PCR in the news

Filtered to PCR · Simplify

PCR Dividends

Last payment
$0.18 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Monthly

Distribution data unavailable.

Distribution history

2025–2026

One bar per payment. 12 payments from 2025 to 2026 YTD. Oct 28, 2025 $0.06; Nov 21, 2025 $0.24; Dec 23, 2025 $0.23; Jan 27, 2026 $0.24; Feb 24, 2026 $0.20; Mar 26, 2026 $0.19; Apr 27, 2026 $0.19; May 26, 2026 $0.19; Jun 25, 2026 $0.19; Jul 28, 2026 $0.19; Aug 26, 2026 $0.19; Sep 25, 2026 $0.18. Use the arrow keys to read each point.20252026YTD
Ex-datePay dateAmount per share
Sep 25, 2026Sep 30, 2026$0.18
Aug 26, 2026Aug 31, 2026$0.19
Jul 28, 2026Jul 31, 2026$0.19
Jun 25, 2026Jun 30, 2026$0.19
May 26, 2026May 29, 2026$0.19
Apr 27, 2026Apr 30, 2026$0.19
Mar 26, 2026Mar 31, 2026$0.19
Feb 24, 2026Feb 27, 2026$0.20
Jan 27, 2026Jan 30, 2026$0.24
Dec 23, 2025Dec 31, 2025$0.23
Nov 21, 2025Nov 28, 2025$0.24
Oct 28, 2025Oct 31, 2025$0.06

PCR Risk

How much the fund’s monthly returns vary, scaled to a year.
17.2%
Annualised · 12 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
−1.31
vs 3-month T-bills · 12 months to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−21.5%
12 months · trough Oct 2026
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.54
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

PCR Cost

Expense ratio0.76%

PCR costs $76.00 a year on $10,000.